|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.660 USD | -0.21% |
|
-.--% | +3.10% |
| Apr. 15 | Evotec Taps CureVac Executive as COO | MT |
| Jan. 06 | CureVac ends coverage after BioNTech acquisition |  |
Executive Committee: CureVac
| Manager | Positions heldSince | ||
|---|---|---|---|
![Alexander Zehnder](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>) Alexander Zehnder 56 year |
| ||
Malte Greune 61 year |
| ||
Myriam Mendila 60 year |
|
Composition of the Board of Directors: CureVac
| Director | CommitteesSince | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Baron Jean Stéphenne 75 year |
| ||||||||
Michael Brosnan 71 year |
| ||||||||
Birgit Hofmann 60 year |
| ||||||||
Debra Stephanie Barker 63 year |
| ||||||||
Mathias Hothum 58 year |
| ||||||||
Klaus Schollmeier 69 year |
| ||||||||
Mehdi Shahidi 60 year |
|
Latest Appointments: CureVac
Former Officers and Directors: CureVac
| Insider | Positions held SinceUntil | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
 |
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
|
Age distribution of managers
Parity Men Women
| Male | 10 |
|---|---|
| Female | 0 |
Of which Executive Committee
| Male | 3 |
|---|---|
| Female | 0 |
Of which Directors
| Male | 7 |
|---|---|
| Female | 0 |
Revisions
ESG MSCI
Departures of Key Persons
Chief Executive Officer
2020-07-31 2023-03-30
- Stock Market
- Stocks
- CVAC Stock
- Company CureVac
- Governance
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
